Contact us   |  

Which patients with myelofibrosis should receive ruxolitinib therapy? ELN-SIE evidence-based recommendations

Subnetwork: Myeloid malignancies

Disease group/s: Myelofibrosis

Scope and Purpose: 3. Treatment

Patients' involvement?: No

Rigour of development: A - Evidence and consensus based

Link: https://www.ncbi.nlm.nih.gov/pubmed/27740634